Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 22,686 Shares

Key Points

  • Director Douglas Roeder bought 22,686 shares of Senseonics at $5.56 each, increasing his stake by 18.6%. The purchase totaled about $126,134 and was disclosed in an SEC filing.
  • The stock was down 4.5% and opened at $5.50, well below its 52-week high of $12.58. Senseonics has a market cap of about $229.9 million and remains unprofitable.
  • Senseonics reported a Q1 EPS loss of $0.71, missing estimates, while analysts still see more losses ahead. HC Wainwright kept a Buy rating but cut its price target to $14 from $18.50, suggesting optimism tempered by lower near-term expectations.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) Director Douglas Roeder bought 22,686 shares of the firm's stock in a transaction on Tuesday, May 12th. The stock was purchased at an average price of $5.56 per share, with a total value of $126,134.16. Following the transaction, the director owned 144,635 shares in the company, valued at $804,170.60. The trade was a 18.60% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Senseonics Holdings, Inc. Common Stock Trading Down 4.5%

NASDAQ SENS opened at $5.50 on Thursday. Senseonics Holdings, Inc. Common Stock has a 52 week low of $4.79 and a 52 week high of $12.58. The company has a current ratio of 3.51, a quick ratio of 4.55 and a debt-to-equity ratio of 1.05. The company has a market cap of $229.90 million, a PE ratio of -2.75 and a beta of 1.05. The stock has a 50-day moving average price of $6.41.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing the consensus estimate of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 129.97% and a negative net margin of 213.87%.The firm had revenue of $11.71 million during the quarter. As a group, equities research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.53 earnings per share for the current fiscal year.

More Senseonics Holdings, Inc. Common Stock News




Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

  • Positive Sentiment: HC Wainwright raised its earnings estimates across multiple periods, including Q2 2026, Q3 2026, Q4 2026, FY2026, FY2027, FY2028, FY2029, and FY2030, indicating improving expectations for the company’s loss trajectory and longer-term profitability.
  • Positive Sentiment: The analyst maintained a Buy rating and a $14 price target, which still implies meaningful upside from current levels.
  • Positive Sentiment: Director Douglas A. Roeder bought 22,686 shares at $5.56, a sign of insider confidence in the business. Article Title
  • Neutral Sentiment: The updated estimates still show Senseonics remaining unprofitable through the forecast period, so investors may be waiting for clearer evidence of revenue growth and margin improvement.
  • Negative Sentiment: The reduction in HC Wainwright’s price target from $18.50 to $14.00 signals lower confidence in the stock’s near-term valuation, which can weigh on sentiment.

Analyst Ratings Changes

Several research analysts have commented on the stock. Stifel Nicolaus decreased their target price on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Monday. HC Wainwright decreased their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating for the company in a research report on Tuesday. Finally, Weiss Ratings began coverage on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday, February 17th. They issued a "sell (d-)" rating for the company. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $17.00.

Get Our Latest Report on SENS

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Jain Global LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $88,000. Captrust Financial Advisors bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $77,000. Hudson Bay Capital Management LP bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $85,000. GSK plc bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at approximately $60,000. Finally, Ausdal Financial Partners Inc. boosted its holdings in shares of Senseonics Holdings, Inc. Common Stock by 50.0% in the third quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company's stock valued at $46,000 after acquiring an additional 35,000 shares in the last quarter. 12.36% of the stock is currently owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

(Get Free Report)

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Senseonics Holdings, Inc. Common Stock?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Senseonics Holdings, Inc. Common Stock and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles